Authors

Addressing Unmet Needs Globally: LEO Pharma’s Commitment to Dermatology

Christophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.

Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD

Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.

Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?

Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.

We are Biologic Coordinators of Dermatology (BCoD)

Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.

Nailing Common, Rare, and Scary Pediatric Nail Conditions and Surgeries

Jane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.

AAD, Janssen, and Kenvue Partner to Mentor Next Generation of Dermatologists

Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.

Study Reveals Majority of US Adults Distrust Health Care System’s Use of AI

A study found that 65.8% of US adults distrust their health care system’s use of AI, highlighting a need for better communication on AI tools.

Closing the Gap in Pediatric Atopic Dermatitis: Experts Push for Steroid-Free Advancements

Discover the latest advancements in pediatric atopic dermatitis care, featuring expert insights on innovative treatments and family-centered management strategies.

Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD

Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.

The Evolving Role of Mohs Surgeons in Advancing Management of laBCC

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

ORKA-001 Advances Toward Yearly Dosing

ORKA-001 by Oruka Therapeutics offers promising yearly dosing for psoriasis, showcasing extended efficacy and safety in early clinical trials.

Color as a Clinical Compass for Skin Cancer Detection

Orit Markowitz, MD, shares how a color-focused strategy helps spot early malignancies—even 2-mm lesions—across all skin tones.

Dermatology NP Practice is Evolving as Demand Increases

There are more than 355,000 nurse practitioners licensed in the United States in a variety of practice areas.

Vitiligo Linked to Insomnia Risk

A new study showed about half of all vitiligo patients from a care system were burdened with the sleeping disorder.

Late-Breaking Data: Super Responders With Delgocitinib for CHE

April Armstrong, MD, MPH, FAAD, discusses her late-breaking presentation at AAD on the treatment response in patients with moderate to severe chronic CHE treated with delgocitinib.

Shin Guard Dermatitis: What's the Diagnosis?

A new allergen, acetophenone azine with generalized autoeczematization, is the cause of “shin guard dermatitis.”

Cosmetic procedure complications in darker skin

Some adverse reactions to cosmetic procedures occur more often in patients with darker skin types. Patients should be counseled on appropriate cosmetic procedures for their skin type, according to Cheryl M. Burgess, M.D., at the Skin of Color Update virtual meeting.

Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies

Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.

How to get paid for injection administrations

Getting denied for injection administration can be common. How to make sure you get paid.

Restoring Facial Balance and Other Aesthetic Concerns After Weight Loss

Explore solutions for facial volume loss, skin laxity, and in some cases—skin excess.

Severe Hemorrhage from Infantile Hemangioma

A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.